Research

Hormonal

Semaglutide (Ozempic) induces significant weight loss in obese patients primarily through appetite suppression and reduced energy intake, with efficacy directly correlated to dosage.

Semaglutide is an effective tool for weight loss, working by reducing hunger and calorie intake rather than burning more fat directly. It requires a weekly injection with a specific titration schedule to manage side effects like nausea. While effective, it is not a magic bullet; long-term safety data is still emerging, and it is contraindicated for people with certain thyroid or pancreatic histories.

ModerateSupportsMEDIUM confidence
Among the main results is weight loss, which is directly conditioned to the dosage of medication, as well as a better energy intake and a lower preference for fatty foods in the patients' choice.
Hanna Benayon Oliveira Sabbá et al. · Research Society and Development · 2022

Why this rating

The paper is an integrative review of secondary literature, not a primary clinical trial, and notes limited long-term human data.

Source

Ozempic (Semaglutide) for the treatment of obesity: advantages and disadvantages from an integrative analysis

Hanna Benayon Oliveira Sabbá et al. · Research Society and Development · 2022

DOI 10.33448/rsd-v11i11.33963

narrative_reviewCited 8×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →